This brand new report examines the forthcoming prospects for respiratory drugs over the next 5 year. With in-depth sales forecasts for leading pharmaceutical products, the report has been produced to inform you of future developments and strategies. The respiratory market generated revenues of $30503m in 2006, but what will it be in 2013,? Which year will see it reach its peak? This report tells you.
The respiratory market contained ten blockbuster drugs in 2006, with the top three being; Advair/Seretide, Singulair and Zyrtec. predicts that there will be room for more blockbusters as the current products lose patent protection. This detailed report also highlights pipeline developments and important contemporary issues, especially commercial drivers and restraints.
The prevalence of respiratory diseases such as asthma, in the leading pharmaceutical markets, has increased significantly over the past few decades. Although there is some evidence to suggest that the rate of increase is slowing, we believe that the prevalence will continue to increase and be a key driver of this market throughout the forecast period of the report.
Sources include primary interviews and analysis unavailable elsewhere, in-house industry databases, commercial news, published reports, economic research and consultation with experts. Visiongain applies financial forecasting, qualitative analyses and the assessment of unmet needs to provide a comprehensive market report with detailed analysis and informed opinion.
In particular, The Respiratory Market concentrates on the following essential aspects of the market:
Discussion of the current pharmaceutical market
Forecast of the worldwide pharmaceutical market from 2008-2013
Drivers and restraints facing the respiratory market
Opportunities and threats facing the respiratory market
Growth of the respiratory drugs market between 2008-2013
Commercial prospects for the market-leading drugs, with sales forecasts from 2008-2013
Individual forecasts of the leading drug classes from 2008-2013
The potential of generics manufacturers to penetrate this market
Pipeline developments with blockbuster potential
Currently marketed drugs with blockbuster potential
Discussion of unmet therapeutic needs and relative advantages of products
Why you should buy this report:
To receive a comprehensive analysis of the prospects for respiratory drugs from 2008-2013
To discover predicted revenues, growth rates and other key metrics for leading pharmaceutical treatments from 2008-2013
To determine key activities of leading companies
To discover hot pipeline developments and up-and-coming products
To determine the forces that influence the market for respiratory products:
Competitive characteristics of the market
Drivers
Restraints
Strengths, weaknesses, opportunities and threats (SWOT analysis)
To find out where the market is heading - both technologically and commercially
Do you know what the market values of these major therapeutic areas of the respiratory market are?
The report provides in-depth market analysis upon these areas, and extensively identifies both prescription and OTC respiratory drugs by product type. The study also assess' the challenges faced by respiratory companies, and what exciting market opportunities exist in this up- and-coming therapeutic area.
Why You Must Buy This Report?
This report features over 40 figures & graphs, 15 tables and charts, news, insights, the latest developments and an in depth survey of the respiratory market with up-to-date analysis. This report is a vital addition to gaining an understanding of this highly profitable market sector and will give your company 'the edge' on your competitors. You can not afford to be without this latest report
